Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7ra01100h Click here for additional data file.

Cross-linked multilamellar liposomes offer an approach to achieve combinatorial delivery of hydrophobic paclitaxel and hydrophilic metallic carboplatin at a synergistic ratio to treat ovarian cancer.

• Publication year

  2017

• Venue

  RSC Advances

• Publication date

  2017-03-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c7ra01100hPMID 28603607PMCID 5450007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.

  2015cited by this paper
• Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.

  2015cited by this paper
• Advances and challenges in the use of nanoparticles to optimize PK/PD interactions of combined anti-cancer therapies.

  2015cited by this paper
• Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.

  2015cited by this paper
• Clickable protein nanocapsules for targeted delivery of recombinant p53 protein.

  2014cited by this paper
• Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor

  2014cited by this paper
• Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer

  2014cited by this paper
• Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer

  2014cited by this paper
• Encapsulation in Nanoparticles Improves Anti-cancer Efficacy of Carboplatin

  2014cited by this paper
• Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity

  2014cited by this paper
• Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs.

  2013cited by this paper
• PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.

  2013cited by this paper
• Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

  2013cited by this paper
• Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

  2013cited by this paper
• Enhanced Therapeutic Efficacy of iRGD-Conjugated Crosslinked Multilayer Liposomes for Drug Delivery

  2013cited by this paper
• Prognostic Value of Cancer Stem Cell Marker Aldehyde Dehydrogenase in Ovarian Cancer: A Meta-Analysis

  2013cited by this paper
• The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.

  2012cited by this paper
• Nanoparticles as drug delivery systems

  2012cited by this paper
• A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance.

  2012cited by this paper
• Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro.

  2011cited by this paper
• Pharmacokinetic Evaluation of Paclitaxel in South Indian Cancer Patients: A Prospective Study

  2011cited by this paper
• Lipoplatin Formulation Review Article

  2011cited by this paper
• Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.

  2010cited by this paper
• Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.

  2010cited by this paper
• Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance

  2010cited by this paper
• Cellular Responses to Cisplatin-Induced DNA Damage

  2010cited by this paper
• Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles.

  2010cited by this paper
• Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

  2009cited by this paper
• Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

  2009cited by this paper
• The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome.

  2009cited by this paper
• Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression.

  2007cited by this paper
• Inaugural Article: Insights into the mechanism of microtubule stabilization by Taxol

  2006cited by this paper
• Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

  2006cited by this paper
• Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment.

  2006cited by this paper
• Clinical Pharmacokinetics of Carboplatin

  1991cited by this paper
• Clinical pharmacokinetics of carboplatin.

  1991cited by this paper
• Sequences of taxol and cisplatin: a phase I and pharmacologic study.

  1991cited by this paper

• Engineered Multilamellar Cationic Liposomes with High Loading Efficiency and Stability for Enhanced Transdermal Delivery.

  2025cites this paper
• Optimized PEGylated paclitaxel and 6-gingerol co-loaded liposomes induce G2/M phase arrest and apoptosis in MDA-MB-231 breast and A549 lung cancer cells

  2025cites this paper
• Recent Advances in Diagnostic Strategies and Nanotechnology-Based Therapies for Ovarian Cancer Treatment.

  2025cites this paper
• Multilamellar hyaluronic acid-b-poly(lactic acid) polymersomes for pathology-responsive MRI enhancement

  2025cites this paper
• Paclitaxel and Carboplatin in Combination with Low-Intensity Pulsed Ultrasound for Glioblastoma.

  2024cites this paper
• Green waterborne synthesis of hemocompatible polycarbonate–polyether polyurethanes

  2024cites this paper
• Carboplatin‐loaded zeolitic imidazolate framework‐8: Induction of antiproliferative activity and apoptosis in breast cancer cell

  2024cites this paper
• Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells

  2024cites this paper
• Platinum-based chemotherapy: trends in organic nanodelivery systems.

  2024cites this paper
• Molecular mechanisms of cisplatin resistance in ovarian cancer

  2023cites this paper
• Platinum-Based Drugs in Cancer Treatment: Expanding Horizons and Overcoming Resistance

  2023cites this paper
• In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment

  2023cites this paper
• Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy.

  2023cites this paper
• Nano-scale drug delivery systems for Carboplatin: A comprehensive review

  2023cites this paper
• Carboplatin niosomal nanoplatform for potentiated chemotherapy.

  2022cites this paper
• Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs

  2022cites this paper
• Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects

  2022cites this paper
• Nanocarriers containing platinum compounds for combination chemotherapy

  2022cites this paper
• Advanced drug delivery systems in the treatment of ovarian cancer

  2021cites this paper
• Clinical Efficacy of Fuzheng Guben Anticancer Decoction Combined with Taxol in Treating Ovarian Carcinoma and Its Effect on Complication Incidence

  2021cites this paper
• Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer.

  2021cites this paper
• Lipid, Polymeric, Inorganic-based Drug Delivery Applications for Platinum-based Anticancer Drugs.

  2021cites this paper
• Image-guided thermosensitive liposomes for focused ultrasound enhanced co-delivery of carboplatin and SN-38 against triple negative breast cancer in mice.

  2021cites this paper
• pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma

  2021cites this paper
• Cisplatin and paclitaxel co-delivery nanosystem for ovarian cancer chemotherapy.

  2021cites this paper
• Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.

  2021cites this paper
• S doped Cu2O-CuO nanoneedles array: Free standing oxygen evolution electrode with high efficiency and corrosion resistance for seawater splitting

  2021cites this paper
• Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles

  2020cites this paper
• Ovarian Cancer Biomarkers: Moving Forward in Early Detection.

  2020cites this paper
• Nanoparticle delivery systems to combat drug resistance in ovarian cancer.

  2020cites this paper
• Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance

  2020cites this paper
• KRAS/NRAS/BRAF mutation status in patients with liver metastases of colorectal cancer

  2020cites this paper
• Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles

  2020cites this paper
• Photohyperthermal therapy using liposomally formulated indocyanine green for feline nasal lymphoma: A case report.

  2020cites this paper
• Recent advances in drug delivery systems for targeting cancer stem cells

  2020cites this paper
• Combretastatin A4-camptothecin micelles as combination therapy for effective anticancer activity

  2019cites this paper
• Use of anticancer platinum compounds in combination therapies and challenges in drug delivery.

  2018cites this paper
• Tumor Microenvironment Targeted Nanotherapy

  2018cites this paper
• Pentacyclic triterpenoids: Discovery of new drugs with antitumour activity

  2017cites this paper
• Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds.

  2017cites this paper